APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhalation CDMO Industry Growth and Trends Forecast to 2032

24 December 2025114 pages

Choose your research edition.

Industry ResearchInhalation CDMO Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation CDMO Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Inhalation CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation CDMO Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation CDMO Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Inhalation CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Inhalation CDMO market include Aptar Pharma, Bend Bioscience, Bespak, Catalent, CritiTech, Enteris Biopharma, Experic, HCmed and Hovione, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhalation CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhalation CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalation CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalation CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Inhalation CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhalation CDMO Market by Company

Aptar Pharma

Bend Bioscience

Bespak

Catalent

CritiTech

Enteris Biopharma

Experic

HCmed

Hovione

Iconovo

Kindeva

Lonza

Particle Sciences

Proveris

Recipharm

Renejix

Ritedose

Vectura

Sanner

Inhalation CDMO Segment by Type

Soft Mist Inhalers (SMIs)

Dry Powder Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Others

Inhalation CDMO Segment by Application

Commercial

Academic Research

Others

Inhalation CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Inhalation CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Inhalation CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Inhalation CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Inhalation CDMO Market Share by Region (2021-2026) Table 4. Global Inhalation CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Inhalation CDMO Market Share by Region (2027-2032) Table 6. Global Inhalation CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Inhalation CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Inhalation CDMO Market Size Share by Type (2021-2026) Table 9. Global Inhalation CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Inhalation CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Inhalation CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Inhalation CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Inhalation CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Inhalation CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Inhalation CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Inhalation CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Inhalation CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Inhalation CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Inhalation CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Inhalation CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Inhalation CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Inhalation CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Inhalation CDMO Market Size Share by Application (2021-2026) Table 24. Global Inhalation CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Inhalation CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Inhalation CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Inhalation CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Inhalation CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Inhalation CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Inhalation CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Inhalation CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Inhalation CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Inhalation CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Inhalation CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Inhalation CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Inhalation CDMO Industry Trends Table 37. Inhalation CDMO Industry Drivers Table 38. Inhalation CDMO Industry Opportunities and Challenges Table 39. Inhalation CDMO Industry Restraints Table 40. Global Inhalation CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Inhalation CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Inhalation CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Inhalation CDMO Key Company Headquarters & Area Served Table 44. Global Inhalation CDMO Company, Product Type & Application Table 45. Global Inhalation CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Inhalation CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aptar Pharma Company Information Table 49. Aptar Pharma Business Overview Table 50. Aptar Pharma Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aptar Pharma Inhalation CDMO Product Portfolio Table 52. Aptar Pharma Recent Development Table 53. Bend Bioscience Company Information Table 54. Bend Bioscience Business Overview Table 55. Bend Bioscience Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Bend Bioscience Inhalation CDMO Product Portfolio Table 57. Bend Bioscience Recent Development Table 58. Bespak Company Information Table 59. Bespak Business Overview Table 60. Bespak Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bespak Inhalation CDMO Product Portfolio Table 62. Bespak Recent Development Table 63. Catalent Company Information Table 64. Catalent Business Overview Table 65. Catalent Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Catalent Inhalation CDMO Product Portfolio Table 67. Catalent Recent Development Table 68. CritiTech Company Information Table 69. CritiTech Business Overview Table 70. CritiTech Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. CritiTech Inhalation CDMO Product Portfolio Table 72. CritiTech Recent Development Table 73. Enteris Biopharma Company Information Table 74. Enteris Biopharma Business Overview Table 75. Enteris Biopharma Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Enteris Biopharma Inhalation CDMO Product Portfolio Table 77. Enteris Biopharma Recent Development Table 78. Experic Company Information Table 79. Experic Business Overview Table 80. Experic Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Experic Inhalation CDMO Product Portfolio Table 82. Experic Recent Development Table 83. HCmed Company Information Table 84. HCmed Business Overview Table 85. HCmed Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. HCmed Inhalation CDMO Product Portfolio Table 87. HCmed Recent Development Table 88. Hovione Company Information Table 89. Hovione Business Overview Table 90. Hovione Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hovione Inhalation CDMO Product Portfolio Table 92. Hovione Recent Development Table 93. Iconovo Company Information Table 94. Iconovo Business Overview Table 95. Iconovo Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Iconovo Inhalation CDMO Product Portfolio Table 97. Iconovo Recent Development Table 98. Kindeva Company Information Table 99. Kindeva Business Overview Table 100. Kindeva Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Kindeva Inhalation CDMO Product Portfolio Table 102. Kindeva Recent Development Table 103. Lonza Company Information Table 104. Lonza Business Overview Table 105. Lonza Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Lonza Inhalation CDMO Product Portfolio Table 107. Lonza Recent Development Table 108. Particle Sciences Company Information Table 109. Particle Sciences Business Overview Table 110. Particle Sciences Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Particle Sciences Inhalation CDMO Product Portfolio Table 112. Particle Sciences Recent Development Table 113. Proveris Company Information Table 114. Proveris Business Overview Table 115. Proveris Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Proveris Inhalation CDMO Product Portfolio Table 117. Proveris Recent Development Table 118. Recipharm Company Information Table 119. Recipharm Business Overview Table 120. Recipharm Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Recipharm Inhalation CDMO Product Portfolio Table 122. Recipharm Recent Development Table 123. Renejix Company Information Table 124. Renejix Business Overview Table 125. Renejix Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Renejix Inhalation CDMO Product Portfolio Table 127. Renejix Recent Development Table 128. Ritedose Company Information Table 129. Ritedose Business Overview Table 130. Ritedose Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Ritedose Inhalation CDMO Product Portfolio Table 132. Ritedose Recent Development Table 133. Vectura Company Information Table 134. Vectura Business Overview Table 135. Vectura Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Vectura Inhalation CDMO Product Portfolio Table 137. Vectura Recent Development Table 138. Sanner Company Information Table 139. Sanner Business Overview Table 140. Sanner Inhalation CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Sanner Inhalation CDMO Product Portfolio Table 142. Sanner Recent Development Table 143. North America Inhalation CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Inhalation CDMO Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Inhalation CDMO Market Share by Country (2021-2026) Table 146. North America Inhalation CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Inhalation CDMO Market Share Forecast by Country (2027-2032) Table 148. Europe Inhalation CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Inhalation CDMO Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Inhalation CDMO Market Share by Country (2021-2026) Table 151. Europe Inhalation CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Inhalation CDMO Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Inhalation CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Inhalation CDMO Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Inhalation CDMO Market Share by Country (2021-2026) Table 156. Asia-Pacific Inhalation CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Inhalation CDMO Market Share Forecast by Country (2027-2032) Table 158. Latin America Inhalation CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Inhalation CDMO Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Inhalation CDMO Market Share by Country (2021-2026) Table 161. Latin America Inhalation CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Inhalation CDMO Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Inhalation CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Inhalation CDMO Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Inhalation CDMO Market Share by Country (2021-2026) Table 166. Middle East & Africa Inhalation CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Inhalation CDMO Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Inhalation CDMO Product Image Figure 3. Global Inhalation CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Inhalation CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Inhalation CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Inhalation CDMO Market Share by Region (2021-2032) Figure 7. North America Inhalation CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Inhalation CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Inhalation CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Inhalation CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Inhalation CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Soft Mist Inhalers (SMIs) Image Figure 13. Global Soft Mist Inhalers (SMIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Dry Powder Inhalers (DPIs) Image Figure 15. Global Dry Powder Inhalers (DPIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Metered Dose Inhalers (MDIs) Image Figure 17. Global Metered Dose Inhalers (MDIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Inhalation CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Inhalation CDMO Market Share by Type 2025 VS 2032 Figure 22. North America Inhalation CDMO Market Size Share by Type (2021-2032) Figure 23. Europe Inhalation CDMO Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Inhalation CDMO Market Size Share by Type (2021-2032) Figure 25. Latin America Inhalation CDMO Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Inhalation CDMO Market Size Share by Type (2021-2032) Figure 27. Commercial Image Figure 28. Global Commercial Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Academic Research Image Figure 30. Global Academic Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Inhalation CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Inhalation CDMO Market Share by Application 2025 VS 2032 Figure 35. North America Inhalation CDMO Market Size Share by Application (2021-2032) Figure 36. Europe Inhalation CDMO Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Inhalation CDMO Market Size Share by Application (2021-2032) Figure 38. Latin America Inhalation CDMO Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Inhalation CDMO Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Inhalation CDMO Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Inhalation CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Inhalation CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Inhalation CDMO Market Share by Country (2021-2032) Figure 45. Europe Inhalation CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Inhalation CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhalation CDMO Market Share by Country (2021-2032) Figure 48. Asia-Pacific Inhalation CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Inhalation CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Inhalation CDMO Market Share by Country (2021-2032) Figure 51. Latin America Inhalation CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Inhalation CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Inhalation CDMO Market Share by Country (2021-2032) Figure 54. Middle East & Africa Inhalation CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Inhalation CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Inhalation CDMO Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Mist Inhalers (SMIs)
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Others
Applications
  • Commercial
  • Academic Research
  • Others
Companies covered
  • Aptar Pharma
  • Bend Bioscience
  • Bespak
  • Catalent
  • CritiTech
  • Enteris Biopharma
  • Experic
  • HCmed
  • Hovione
  • Iconovo
  • Kindeva
  • Lonza
  • Particle Sciences
  • Proveris
  • Recipharm
  • Renejix
  • Ritedose
  • Vectura
  • Sanner

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Inhalation CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Inhalation CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Inhalation CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Inhalation CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Inhalation CDMO Market Size (2021-2032)
  8. 1.5.1 North America Inhalation CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Inhalation CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Inhalation CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Inhalation CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Inhalation CDMO Market Size Growth Rate (2021-2032)
2 Inhalation CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Soft Mist Inhalers (SMIs)
  3. 2.1.2 Dry Powder Inhalers (DPIs)
  4. 2.1.3 Metered Dose Inhalers (MDIs)
  5. 2.1.4 Others
  6. 2.2 Global Inhalation CDMO Market Size by Type
  7. 2.2.1 Global Inhalation CDMO Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Inhalation CDMO Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Inhalation CDMO Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Inhalation CDMO Market Size by Regions
  11. 2.3.1 North America Inhalation CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Inhalation CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Inhalation CDMO Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Inhalation CDMO Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Inhalation CDMO Market Size Breakdown by Type (2021-2026)
3 Inhalation CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Commercial
  3. 3.1.2 Academic Research
  4. 3.1.3 Others
  5. 3.2 Global Inhalation CDMO Market Size by Application
  6. 3.2.1 Global Inhalation CDMO Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Inhalation CDMO Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Inhalation CDMO Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Inhalation CDMO Market Size by Regions
  10. 3.3.1 North America Inhalation CDMO Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Inhalation CDMO Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Inhalation CDMO Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Inhalation CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Inhalation CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Inhalation CDMO Industry Trends
  2. 4.2 Inhalation CDMO Industry Drivers
  3. 4.3 Inhalation CDMO Industry Opportunities and Challenges
  4. 4.4 Inhalation CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Inhalation CDMO Revenue (2021-2026)
  2. 5.2 Global Inhalation CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Inhalation CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Inhalation CDMO Company, Product Type & Application
  5. 5.5 Global Inhalation CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Inhalation CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Inhalation CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Inhalation CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aptar Pharma
  2. 6.1.1 Aptar Pharma Company Information
  3. 6.1.2 Aptar Pharma Business Overview
  4. 6.1.3 Aptar Pharma Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aptar Pharma Inhalation CDMO Product Portfolio
  6. 6.1.5 Aptar Pharma Recent Developments
  7. 6.2 Bend Bioscience
  8. 6.2.1 Bend Bioscience Company Information
  9. 6.2.2 Bend Bioscience Business Overview
  10. 6.2.3 Bend Bioscience Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Bend Bioscience Inhalation CDMO Product Portfolio
  12. 6.2.5 Bend Bioscience Recent Developments
  13. 6.3 Bespak
  14. 6.3.1 Bespak Company Information
  15. 6.3.2 Bespak Business Overview
  16. 6.3.3 Bespak Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bespak Inhalation CDMO Product Portfolio
  18. 6.3.5 Bespak Recent Developments
  19. 6.4 Catalent
  20. 6.4.1 Catalent Company Information
  21. 6.4.2 Catalent Business Overview
  22. 6.4.3 Catalent Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Catalent Inhalation CDMO Product Portfolio
  24. 6.4.5 Catalent Recent Developments
  25. 6.5 CritiTech
  26. 6.5.1 CritiTech Company Information
  27. 6.5.2 CritiTech Business Overview
  28. 6.5.3 CritiTech Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 CritiTech Inhalation CDMO Product Portfolio
  30. 6.5.5 CritiTech Recent Developments
  31. 6.6 Enteris Biopharma
  32. 6.6.1 Enteris Biopharma Company Information
  33. 6.6.2 Enteris Biopharma Business Overview
  34. 6.6.3 Enteris Biopharma Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Enteris Biopharma Inhalation CDMO Product Portfolio
  36. 6.6.5 Enteris Biopharma Recent Developments
  37. 6.7 Experic
  38. 6.7.1 Experic Company Information
  39. 6.7.2 Experic Business Overview
  40. 6.7.3 Experic Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Experic Inhalation CDMO Product Portfolio
  42. 6.7.5 Experic Recent Developments
  43. 6.8 HCmed
  44. 6.8.1 HCmed Company Information
  45. 6.8.2 HCmed Business Overview
  46. 6.8.3 HCmed Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 HCmed Inhalation CDMO Product Portfolio
  48. 6.8.5 HCmed Recent Developments
  49. 6.9 Hovione
  50. 6.9.1 Hovione Company Information
  51. 6.9.2 Hovione Business Overview
  52. 6.9.3 Hovione Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hovione Inhalation CDMO Product Portfolio
  54. 6.9.5 Hovione Recent Developments
  55. 6.10 Iconovo
  56. 6.10.1 Iconovo Company Information
  57. 6.10.2 Iconovo Business Overview
  58. 6.10.3 Iconovo Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Iconovo Inhalation CDMO Product Portfolio
  60. 6.10.5 Iconovo Recent Developments
  61. 6.11 Kindeva
  62. 6.11.1 Kindeva Company Information
  63. 6.11.2 Kindeva Business Overview
  64. 6.11.3 Kindeva Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Kindeva Inhalation CDMO Product Portfolio
  66. 6.11.5 Kindeva Recent Developments
  67. 6.12 Lonza
  68. 6.12.1 Lonza Company Information
  69. 6.12.2 Lonza Business Overview
  70. 6.12.3 Lonza Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Lonza Inhalation CDMO Product Portfolio
  72. 6.12.5 Lonza Recent Developments
  73. 6.13 Particle Sciences
  74. 6.13.1 Particle Sciences Company Information
  75. 6.13.2 Particle Sciences Business Overview
  76. 6.13.3 Particle Sciences Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Particle Sciences Inhalation CDMO Product Portfolio
  78. 6.13.5 Particle Sciences Recent Developments
  79. 6.14 Proveris
  80. 6.14.1 Proveris Company Information
  81. 6.14.2 Proveris Business Overview
  82. 6.14.3 Proveris Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Proveris Inhalation CDMO Product Portfolio
  84. 6.14.5 Proveris Recent Developments
  85. 6.15 Recipharm
  86. 6.15.1 Recipharm Company Information
  87. 6.15.2 Recipharm Business Overview
  88. 6.15.3 Recipharm Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Recipharm Inhalation CDMO Product Portfolio
  90. 6.15.5 Recipharm Recent Developments
  91. 6.16 Renejix
  92. 6.16.1 Renejix Company Information
  93. 6.16.2 Renejix Business Overview
  94. 6.16.3 Renejix Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Renejix Inhalation CDMO Product Portfolio
  96. 6.16.5 Renejix Recent Developments
  97. 6.17 Ritedose
  98. 6.17.1 Ritedose Company Information
  99. 6.17.2 Ritedose Business Overview
  100. 6.17.3 Ritedose Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Ritedose Inhalation CDMO Product Portfolio
  102. 6.17.5 Ritedose Recent Developments
  103. 6.18 Vectura
  104. 6.18.1 Vectura Company Information
  105. 6.18.2 Vectura Business Overview
  106. 6.18.3 Vectura Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Vectura Inhalation CDMO Product Portfolio
  108. 6.18.5 Vectura Recent Developments
  109. 6.19 Sanner
  110. 6.19.1 Sanner Company Information
  111. 6.19.2 Sanner Business Overview
  112. 6.19.3 Sanner Inhalation CDMO Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Sanner Inhalation CDMO Product Portfolio
  114. 6.19.5 Sanner Recent Developments
7 North America
  1. 7.1 North America Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Inhalation CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Inhalation CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Inhalation CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Inhalation CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Inhalation CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Inhalation CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Inhalation CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Inhalation CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Inhalation CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Inhalation CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst